Monitor for any strategic shifts under Fabian's commercial leadership, particularly around TULSA-PRO adoption and Sonalleve expansion. The next quarterly earnings call will be the first opportunity to gauge execution changes.
Price Chart
Executive Summary
Profound Medical appointed Richard Fabian as President, effective September 1, 2026, succeeding Mathieu Burtnyk who moved to the newly created Chief Technology Officer role. Fabian brings deep medical device and imaging leadership from FUJIFILM Sonosite and Philips Healthcare. This is a routine executive restructuring with no financial data or guidance provided, making it a neutral event for traders.
Key Facts
- Richard Fabian appointed President effective September 1, 2026
- Mathieu Burtnyk shifted to newly created Chief Technology Officer role
- Fabian previously President and CEO of FUJIFILM Sonosite (2017-2026) and held executive roles at Philips Healthcare
- Employment agreement: $550,000 annual base salary, up to 100% bonus, 200,000 RSUs (3-year vest), options for 475,000 shares (4-year vest)
- Company will lease a Toronto residence for Fabian during initial 12 months
- No financial results, guidance, or material operational updates disclosed
Financial Impact
No financial impact disclosed — executive appointment only
Risk Factors
- No financial data or guidance provided — limited trading signal
- Executive transition risk if Fabian's commercial focus diverges from prior R&D-driven strategy
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-005868 |
| Exhibit: exh_991.htm | 0001171843-26-005868 |
| Document: 0001171843-26-005868-index-headers.html | 0001171843-26-005868 |
| Document: 0001171843-26-005868-index.html | 0001171843-26-005868 |
| Document: 0001171843-26-005868.txt | 0001171843-26-005868 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $6.89 $5.81 | ▼ −15.67% | ▼ −14.47% | $5.85 (−15.09%) |
Sep 3, 2026 29d ago | 8-K | $6.80 $5.97 | ▼ −12.21% | ▼ −11.06% | $5.85 (−13.97%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Jul 24, 2026 10w ago | 8-K | $7.26 $7.25 | ▼ −0.14% | ▼ −0.51% | $5.85 (−19.42%) |
Jul 15, 2026 11w ago | 8-K | $6.96 $6.99 | ▲ +0.43% | ▲ +1.41% | $5.85 (−15.95%) |
May 14, 2026 20w ago | 8-K | $6.97 $6.83 | ▼ −2.01% | ▼ −2.97% | $5.85 (−16.07%) |
May 12, 2026 20w ago | S-3 | $7.10 $6.73 | ▼ −5.21% | ▼ −4.05% | $5.85 (−17.61%) |
Apr 16, 2026 24w ago | 8-K | $6.62 $6.75 | ▲ +1.96% | ▲ +0.98% | $5.85 (−11.63%) |
Apr 14, 2026 24w ago | 8-K | $6.26 $6.84 | ▲ +9.27% | ▲ +7.87% | $5.85 (−6.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access